Navigation Links
2011 ChemOutsourcing Record Attendance Marks 5th Year of Uninterrupted Growth of Annual Pharmaceutical Ingredients Show
Date:8/4/2011

LONG BRANCH, N.J., Aug. 4, 2011 /PRNewswire/ -- ChemOutsourcing today announced that this year's show has already eclipsed last year's attendance marking the 5th straight year of growth, reported Mark Alexay, its President. The annual chemistry and pharmaceutical ingredients show has emerged as an important business gathering of executives from Contract Research and Manufacturing organizations.

This year's show will take place September 12-15 , 2011 at Ocean Place Resort in Long Branch, NJ.

"Part of this year's growth is attributable to the larger pharmaceutical companies investing offshore to lower costs," remarked Alexay. "This has resulted in a growth spike in outsourcing. The industry supply chain has become increasingly globalized and the show is a good place for suppliers and their clients to meet. It also serves primarily the lucrative US market where everyone wants to be."

About 1000 attendees, 110 exhibitors, and 150 speakers attend ChemOutsourcing. Larger companies like Pfizer, Bristol-Myers Squibb, Merck, and Eli Lilly attend the show, and increasingly, small molecule biotech "emerging" pharmaceutical company chemists. The attendee list may be accessed at http://tinyurl.com/4xv8bo7

Alexay continued, "ChemOutsourcing started out as an API and intermediates show in 2007. Since then the show has evolved to include related areas like drug discovery, analytical development, laboratory equipment, and a variety of other pharmaceutical and chemical services. It's a long and convoluted food chain. And with new therapeutics now more difficult to discover and commercialize, everybody is looking for productive partnerships. So the industry has extended itself around the world and the show has grown with it."

The speaker and exhibitor lists can be viewed at http://tinyurl.com/3vxch7f

and http://tinyurl.com/44cn97q

Alexay concluded by remarking, "Our ultimate goal is to attract chemists from every emerging and medium-sized pharmaceutical company in the world – we have all witnessed their tremendous accomplishments in drug discovery and development over the past 10-12 years – and they in turn will attract the investors whose capital is so vital for their, and the industry's, future."

CONTACT: Mark Alexay, President, ChemOutsourcing, Apaporis LLC, +1-201-452-4023, malexay@chemoutsourcing


'/>"/>
SOURCE ChemOutsourcing
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
2. Big Pharma Chemists Turning Out in Large Numbers for ChemOutsourcing Extravaganza Event on September 14-16, 2010 at Jersey Shore Beach Resort
3. Pharma ChemOutsourcing Show Seeking VCs to Address 100 Biotech Companies at September Event in Long Branch, NJ
4. NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011
5. Henry Schein Reports Record Second Quarter Results
6. Groupe Athena, Inc. Profits Soar on Record Revenues
7. Heritage Valley Health System Selects the Sunrise Acute Care Electronic Health Record from Allscripts
8. CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011
9. RSB Spine, LLC, Announces Record Second-Quarter 2011 Revenue
10. AAIPharma Services Builds Compliance Record at Lab, Manufacturing and Packaging Operations
11. Porter Novelli Named Agency of Record for Prix Galien USA Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... ... services to provide one resource, from start to finish, for Life Safety compliance. ... Statement of Condition surveys requested by the Joint Commission, and fire stopping reviews, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Jericho Project has named LaToya Williams-Belfort to ... be responsible for fundraising and communications for the nationally-acclaimed nonprofit, working closely with CEO ... working to end homelessness at its roots. , “LaToya Williams-Belfort is joining Jericho ...
(Date:5/24/2016)... ... May 24, 2016 , ... Educational opportunities, and ... with more advantaged communities providing richer opportunities. Recognizing the key role of housing ... improvement policies; (b) school choice policies; (c) school desegregation policies; (d) wealth-focused policies; ...
(Date:5/24/2016)... ... May 24, 2016 , ... New Brunswick, New Jersey: This year marks ... reach their fullest potential. To commemorate the anniversary, the hospital has themed the milestone ... Roll for Children’s Specialized Hospital Foundation on Saturday, May 21, at Johnson Park in ...
(Date:5/24/2016)... ... (PRWEB) May 24, ... new members of its Advisory Board. Joining the Grow Healthy ... “All three of them embody the mission of our organization and ... fortunate to have them as we continue to expand our footprint ...
Breaking Medicine News(10 mins):